Answers are grounded in this paper and cite their sources.
A 76-year-old man with chronic obstructive pulmonary disease, presented to the dermatology clinic with a 2-year history of persistent, painful, and slowly progressive erosions on the tongue that limited his ability to feed. Four months before consultation, he showed sudden loss of visual acuity in both eyes in the setting of corneal erosion, entropion, conjunctival hyperemia, and inferior conjunctival sac shortening associated with constant ocular itching. Examination revealed an extensive ulcerated plaque covered with fibrin and cartographic edges, as well as focal areas of hyperemia affecting the tongue and vermilion edge of the lower lip. Loss of vermilion border and decrease in oral aperture could be observed (Figure 1). Ophthalmologic evaluation revealed bilateral inferior conjunctival sac shortening, corneal ulcer in the right eye, lipidic keratopathy in the left eye, and posterior blepharitis in both eyes (Figure 2). Two incisional biopsies were obtained from the lip and tongue lesions. Hematoxylin-eosin stained sections (Figure 3), immunohistochemical staining for type IV collagen and direct immunofluorescence were performed. (Figure 4) This patient presented with the involvement of two mucous membranes (oral and conjunctival) with rapid progression of ocular involvement, leading to decreased visual acuity. Histopathology with hematoxlin and eosin revealed a subepithelial cleft with mixed superficial perivascular infiltrate, immunofluorescence direct study showed direct deposition of IgG, IgA and C3. These results confirmed a diagnosis of MMP. In our case, opportune initiation of systemic steroids was performed, and laboratory studies were requested before the initiation of immunomodulatory therapy. Unfortunately, due to difficulties in accessing health services and the pandemic, the patient did not return for consultation. MMP is a scarring subepithelial blistering disease with mucosal predominance and occasional cutaneous involvement.1 MMP can affect one or more sites. Ocular (70% of cases), oral (desquamative gingivitis in up to 65%), nasopharyngeal, laryngeal and genital involvement result in significant morbidity. Ocular complications include chronic cicatrizial conjunctivitis, symblepharon, entropion, trichiasis, glaucoma, erosion and scarring, which may lead to blindness.1, 2 Ocular involvement is considered underdiagnosed (<1 case per million per year). Around 64% of MMP cases present ocular findings, and and some patients can debut with unique ocular compromise.3 Pathophysiologically, there are autoantibodies against components of the basement membrane, mainly bullous pemphigoid (BP)180, BP230, laminin 332, the b4 subunit of the a6b4 integrin.4 Histologic study showed supepithelial split with variable grades of mixed inflammatory infiltrate. The Direct immunofluorescence is considered the Gold standar, identifying IgG, C3 or IgA at the basement membrane zone.5 Early diagnosis and suitable treatment are essential to prevent the severe and limiting consequences of MMP. There is limited evidence to guide therapy, considering the rapid onset of treatment on moderate to severe disease, using prednisolone, dapsone, sulfapyridine, mycophenolate mofetil, azatioprine, intravenous cyclophosphamide, intravenous immunoglobulin or rituximab as options.6, 7 All authors contribute to patient care and article development. The authors declare no conflict of interest. All patients in this manuscript have given written informed consent for participation in the study and the use of their deidentified, anonymized, aggregated data and their case details (including photographs) for publication. This case received ethical approval from the institution. The data that support the findings of this study are available from the corresponding author upon reasonable request.
No takes yet. Share an insight, caveat, or question.
Ocampo et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: